Financhill
Buy
52

TME Quote, Financials, Valuation and Earnings

Last price:
$11.70
Seasonality move :
9.95%
Day range:
$11.65 - $12.03
52-week range:
$8.15 - $15.77
Dividend yield:
1.15%
P/E ratio:
22.33x
P/S ratio:
4.83x
P/B ratio:
2.23x
Volume:
5.1M
Avg. volume:
7.9M
1-year change:
39.44%
Market cap:
$20.2B
Revenue:
$3.9B
EPS (TTM):
$0.54
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3.7B $4.2B $4.8B $4.2B $3.9B
Revenue Growth (YoY) 28.22% 14.73% 14.55% -12.81% -7.01%
 
Cost of Revenues $2.4B $2.9B $3.4B $2.9B $2.5B
Gross Profit $1.3B $1.3B $1.5B $1.3B $1.4B
Gross Profit Margin 34.1% 31.91% 30.1% 30.96% 35.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $686.8M $808M $1B $827.3M $709.4M
Other Inc / (Exp) -$9.8M $20M $17.3M $36.5M $20.5M
Operating Expenses $667.7M $772.5M $974.8M $780.3M $681.8M
Operating Income $587.9M $575.4M $481.7M $525.8M $702.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $657.3M $671.2M $562.5M $651M $854.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $81.5M $66.1M $64.6M $79.5M $116.6M
Net Income to Company $657.3M $671.2M $562.5M $651M $854.6M
 
Minority Interest in Earnings $723.9K -$3M -$28.8M -$24.1M -$42.4M
Net Income to Common Excl Extra Items $576.5M $602.1M $469.1M $547.4M $695.5M
 
Basic EPS (Cont. Ops) $0.35 $0.36 $0.28 $0.34 $0.45
Diluted EPS (Cont. Ops) $0.34 $0.36 $0.28 $0.34 $0.44
Weighted Average Basic Share $1.6B $1.7B $1.7B $1.6B $1.6B
Weighted Average Diluted Share $1.7B $1.7B $1.7B $1.6B $1.6B
 
EBITDA $751.5M $804.9M $736.1M $840.8M $1B
EBIT $667.1M $685.5M $581.1M $668.2M $872.1M
 
Revenue (Reported) $3.7B $4.2B $4.8B $4.2B $3.9B
Operating Income (Reported) $587.9M $575.4M $481.7M $525.8M $702.9M
Operating Income (Adjusted) $667.1M $685.5M $581.1M $668.2M $872.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.1B $1.2B $1.1B $907.8M $979.8M
Revenue Growth (YoY) 17.96% 10.16% -10.79% -15.57% 7.93%
 
Cost of Revenues $739M $848.7M $724.4M $584.1M $562M
Gross Profit $355M $356.5M $350.8M $323.6M $417.7M
Gross Profit Margin 32.45% 29.58% 32.63% 35.65% 42.64%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $206.8M $252.9M $209.8M $175.2M $170.1M
Other Inc / (Exp) $18.5M $18.2M $17.1M $17.6M $14.1M
Operating Expenses $206.8M $252.9M $209.8M $175.2M $170.1M
Operating Income $148.2M $103.6M $141M $148.4M $247.6M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $180.7M $137.4M $181.7M $198.9M $289.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $16.8M $15.8M $22.2M $24.3M $51.3M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$433.3K -$7.4M -$4.7M -$13.1M -$17.6M
Net Income to Common Excl Extra Items $163.5M $114.3M $154.9M $161.4M $221.1M
 
Basic EPS (Cont. Ops) $0.10 $0.07 $0.10 $0.10 $0.14
Diluted EPS (Cont. Ops) $0.10 $0.07 $0.10 $0.10 $0.14
Weighted Average Basic Share $1.7B $1.7B $1.6B $1.6B $1.5B
Weighted Average Diluted Share $1.7B $1.7B $1.6B $1.6B $1.6B
 
EBITDA $186.7M $142.1M $185.2M $203.7M $303.5M
EBIT $186.7M $142.1M $185.2M $203.7M $303.5M
 
Revenue (Reported) $1.1B $1.2B $1.1B $907.8M $979.8M
Operating Income (Reported) $148.2M $103.6M $141M $148.4M $247.6M
Operating Income (Adjusted) $186.7M $142.1M $185.2M $203.7M $303.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4B $4.9B $4.4B $4B $3.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.7B $3.4B $3.1B $2.7B $2.3B
Gross Profit $1.3B $1.5B $1.3B $1.4B $1.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $758.3M $1B $919.2M $725.2M $664.4M
Other Inc / (Exp) $11.2M $6.9M $37.1M $8.7M $11.9M
Operating Expenses $739.6M $943.3M $857.8M $680.8M $637.3M
Operating Income $557.8M $577.3M $440.2M $681.4M $953.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $647.3M $653.7M $553.6M $810.6M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $75.8M $63.5M $66.8M $99M $205.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$570.2K -$24.7M -$22.8M -$35.5M -$62.6M
Net Income to Common Excl Extra Items $570.9M $565.5M $463.9M $676.1M $835.1M
 
Basic EPS (Cont. Ops) $0.34 $0.29 $0.29 $0.43 $0.54
Diluted EPS (Cont. Ops) $0.34 $0.28 $0.28 $0.43 $0.54
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $660.2M $704.7M $570M $831.7M $1.1B
EBIT $660.2M $670.8M $570M $831.7M $1.1B
 
Revenue (Reported) $4B $4.9B $4.4B $4B $3.9B
Operating Income (Reported) $557.8M $577.3M $440.2M $681.4M $953.1M
Operating Income (Adjusted) $660.2M $670.8M $570M $831.7M $1.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3B $3.7B $3.2B $3B $2.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2B $2.5B $2.2B $2B $1.7B
Gross Profit $944.2M $1.1B $955.5M $1B $1.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $557M $752.1M $635.3M $533.9M $488.5M
Other Inc / (Exp) $36.4M $24.4M $69.6M $38.9M $30M
Operating Expenses $557M $727M $635.3M $533.9M $488.5M
Operating Income $387.2M $386.8M $320.2M $484.3M $735M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $478.8M $460.2M $451.7M $617.6M $866.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $55M $52.8M $55.1M $75.4M $164.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$854.1K -$22.4M -$16.4M -$27.9M -$48.3M
Net Income to Common Excl Extra Items $423M $385M $380.2M $514.3M $653.7M
 
Basic EPS (Cont. Ops) $0.25 $0.23 $0.24 $0.33 $0.42
Diluted EPS (Cont. Ops) $0.25 $0.23 $0.23 $0.32 $0.42
Weighted Average Basic Share $5B $5B $4.8B $4.7B $4.6B
Weighted Average Diluted Share $5B $5.1B $4.9B $4.8B $4.7B
 
EBITDA $490.1M $508.1M $463.4M $633.4M $887.9M
EBIT $490.1M $474.2M $463.4M $633.4M $887.9M
 
Revenue (Reported) $3B $3.7B $3.2B $3B $2.9B
Operating Income (Reported) $387.2M $386.8M $320.2M $484.3M $735M
Operating Income (Adjusted) $490.1M $474.2M $463.4M $633.4M $887.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.2B $1.7B $1B $1.4B $1.9B
Short Term Investments $1B $2.3B $2.2B $1.6B $1.4B
Accounts Receivable, Net $314.1M $428.6M $566.4M $387M $411.6M
Inventory $3.7M $2.8M $3.8M $2M $1.1M
Prepaid Expenses $276.1M $398.7M $390.3M $384.4M $451.7M
Other Current Assets $12.1M $8.1M $8.8M $7.7M $8M
Total Current Assets $3.8B $4.9B $4.2B $3.8B $4.2B
 
Property Plant And Equipment $46.7M $74.5M $82.5M $104.5M $120.9M
Long-Term Investments $809.9M $2.3B $2.4B $2.1B $2.8B
Goodwill $2.4B $2.7B $3B $2.8B $2.8B
Other Intangibles $231.8M $309.2M $678.4M $702.7M $630.5M
Other Long-Term Assets -- -- -- $15.4M $15.5M
Total Assets $7.5B $10.5B $10.6B $9.7B $10.7B
 
Accounts Payable $365.7M $545.7M $679.2M $724.4M $706.2M
Accrued Expenses $300.9M $415.9M $491.5M $409.5M $376.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $9.9M $15.8M $14.4M $17.8M $16.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.2B $1.5B $1.6B $1.7B $1.7B
 
Long-Term Debt -- $792.1M $794.2M $802.4M $795.1M
Capital Leases -- -- -- -- --
Total Liabilities $1.3B $2.4B $2.5B $2.6B $2.6B
 
Common Stock $285.8K $306.1K $313.8K $289.9K $282.1K
Other Common Equity Adj $312.6M $964.3M $584.6M $889.9M $1.4B
Common Equity $6.2B $8B $7.9B $7B $7.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $12.6M $74.4M $115.8M $149M $182.7M
Total Equity $6.2B $8.1B $8B $7.1B $8.1B
 
Total Liabilities and Equity $7.5B $10.5B $10.6B $9.7B $10.7B
Cash and Short Terms $3.2B $4B $3.2B $3B $3.3B
Total Debt -- $792.1M $794.2M $802.4M $795.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.4B $784.7M $1.2B $1.7B $1.5B
Short Term Investments $2.2B $2.3B $1.4B $1.3B $2.6B
Accounts Receivable, Net $316.7M $415M $409.2M $342.9M $418.6M
Inventory $3.7M $4.2M $2.8M $685.3K $2.6M
Prepaid Expenses $446.2M $487.1M $592.3M -- --
Other Current Assets -- -- -- $457.5M $427.8M
Total Current Assets $4.4B $4B $3.7B $3.8B $4.9B
 
Property Plant And Equipment $45M $80.8M $101.6M $113.2M $144.9M
Long-Term Investments $2B $2.4B $2B $2.6B $3.5B
Goodwill $2.5B $3B $2.7B $2.7B $2.8B
Other Intangibles $280.1M $427.1M $700.3M $629.4M $624.3M
Other Long-Term Assets $155.7M $354.9M $92.5M $79.5M $64.7M
Total Assets $9.4B $10.3B $9.4B $10B $12.1B
 
Accounts Payable $469.8M $692.4M $678.9M $692.1M $930.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- $299.3M
Current Portion Of Capital Lease Obligations $11M $15.6M $13.9M $15.5M $15.5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $1.3B $1.5B $1.7B $1.6B $2.2B
 
Long-Term Debt $790.9M $795.5M $791.6M $782.9M $496.4M
Capital Leases -- -- -- -- --
Total Liabilities $2.1B $2.4B $2.6B $2.4B $2.8B
 
Common Stock $293K $309K $280.7K $274.1K $285.2K
Other Common Equity Adj $685.7M $555.3M $758.3M $1.2B $2.4B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $15.2M $102.3M $150.2M $169.1M $248.7M
Total Equity $7.2B $7.8B $6.8B $7.6B $9.3B
 
Total Liabilities and Equity $9.4B $10.3B $9.4B $10B $12.1B
Cash and Short Terms $3.6B $3.1B $2.7B $3B $4.1B
Total Debt $790.9M $795.5M $791.6M $782.9M $795.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $657.3M $671.2M $562.5M $651M $854.6M
Depreciation & Amoritzation $84.4M $119.4M $155M $172.7M $141.9M
Stock-Based Compensation $75.1M $82.5M $100.2M $99M $91.7M
Change in Accounts Receivable -$106.1M -$75.4M -$119.1M $134.9M -$28.8M
Change in Inventories $1.3M $1.2M -$929.3K $1.5M $989.6K
Cash From Operations $897.6M $707.9M $811.4M $1.1B $1B
 
Capital Expenditures $41.4M $72.6M $427.2M $156.8M $164.6M
Cash Acquisitions -$6.5M -$76.1M -$321.4M -$21.4M $8.1M
Cash From Investing -$1.2B -$2.1B -$929.1M -$215.3M -$263.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $783.9M -- -- --
Long-Term Debt Repaid -$8.1M -$11.6M -$18M -$19.4M -$16.4M
Repurchase of Common Stock -- -$19.4M -$538.8M -$465.5M -$176.6M
Other Financing Activities -$11.4M -$869.4K -$3.4M -$5.2M -$9.2M
Cash From Financing -$4.5M $766.8M -$574.6M -$509M -$217.4M
 
Beginning Cash (CF) $2.5B $2.2B $1.7B $981.2M $1.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$279.8M -$583.8M -$692.3M $389.5M $556.4M
Ending Cash (CF) $2.2B $1.6B $1B $1.4B $1.9B
 
Levered Free Cash Flow $856.2M $635.3M $384.3M $957M $872.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $83M $245.3M $163M $181.5M $306M
 
Capital Expenditures -- -$136.7M -- -- --
Cash Acquisitions -- $321M -- -- --
Cash From Investing -$1.2B -$259.4M -$186.2M -$155.4M -$469.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- $8.4M -- -- --
Repurchase of Common Stock -- $260.5M -- -- --
Other Financing Activities -- $3.3M -- -- --
Cash From Financing $783.6M -$254.3M -$236.2M -$116.8M -$124.5M
 
Beginning Cash (CF) $1.7B $1.1B $1.5B $1.8B $1.7B
Foreign Exchange Rate Adjustment -$26.1M $636.3K $27.8M -$3.2M $1.7M
Additions / Reductions -$294.6M -$268.4M -$259.5M -$90.7M -$287.7M
Ending Cash (CF) $1.4B $784.1M $1.3B $1.7B $1.4B
 
Levered Free Cash Flow $83M $381.9M $163M $181.5M $306M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- $100.2M -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $740M $953.6M $857.4M $1.1B $1.4B
 
Capital Expenditures $41.4M -- $427.2M -- --
Cash Acquisitions -$6.5M -- -$321.4M -- --
Cash From Investing -$3B -$1.1B $101.7M -$396.7M -$1.2B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $751.1M -$523.4M -$489.1M -$198.7M -$505.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$1.5B -$677.4M $469.9M $531M -$290.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $698.6M $953.6M $857.4M $1.1B $1.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $436.3M $682M $728M $740.7M $1.1B
 
Capital Expenditures -- -$100 -- -- --
Cash Acquisitions -- $0 -- -- --
Cash From Investing -$2B -$1.1B -$49.3M -$230.8M -$1.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- $0 -- -- --
Other Financing Activities -- -$0 -- -- --
Cash From Financing $761.6M -$528.7M -$443.2M -$132.9M -$421.1M
 
Beginning Cash (CF) $5.6B $4.4B $3.9B $5B $5B
Foreign Exchange Rate Adjustment -$2.3M -$7.4M $55.2M $13.5M $558.7K
Additions / Reductions -$833.2M -$926.8M $235.5M $377M -$469.6M
Ending Cash (CF) $4.8B $3.4B $4.1B $5.3B $4.6B
 
Levered Free Cash Flow $436.3M $682M $728M $740.7M $1.1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 1.23% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.75% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock